Related Experiment Videos
Lymphangiectasia haemorrhagica conjunctivae
1Department of Ophthalmology, St Bartholomew's Hospital, London, UK.
Eye (London, England)
|December 16, 1998
Summary
This study re-describes lymphangiectasia haemorrhagica conjunctivae and presents a new argon laser treatment. The laser treatment effectively prevented recurrences in patients with this rare conjunctival condition.
Area of Science:
- Ophthalmology
- Vascular Diseases
Background:
- Lymphangiectasia haemorrhagica conjunctivae is a rare condition.
- The condition has not been extensively documented in recent literature.
Purpose of the Study:
- To re-describe lymphangiectasia haemorrhagica conjunctivae.
- To introduce and evaluate a novel argon laser treatment for this condition.
Main Methods:
- Nine patients with lymphangiectasia haemorrhagica conjunctivae were identified over two years.
- Three patients with recurrent hemorrhages received argon laser treatment.
- Patients were followed for up to two years post-treatment.
Main Results:
- None of the three patients treated with the argon laser experienced recurrence.
- Six untreated patients experienced spontaneous resolution of the condition over 8 months to 8 years.
Conclusions:
- Lymphangiectasia haemorrhagica conjunctivae may be more common than previously thought.
- While spontaneous resolution can occur, argon laser therapy offers an effective treatment for frequent or bothersome hemorrhages.